Determination of cost-effective treatment of acute otitis media from HMO records

American Journal of Health-System Pharmacy

Volumn 54, Issue 23, 1997, Pages 2736-2740

  Branthaver, Beth ^a   Greiner, Deborah L ^b   Eichelberger, Bernadette ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFACLOR; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; PEDIAZOLE; SULFAFURAZOLE; SULFONAMIDE;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; COST EFFECTIVENESS ANALYSIS; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; OTITIS MEDIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030781223     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/54.23.2736     Document Type: Article

References (6)

1. Nelson WE. Textbook of pediatrics. 13th ed. Philadelphia: Saunders; 1987.
2. Oski FA. Principles and practice of pediatrics. Philadelphia: Lippincott-Raven; 1990.
3. Bluestone CD. Modern management of otitis media. Pediatr Clin North Am. 1989; 36:1371-87.
4. Lisby-Sutch SM, Nemec-Dwyer MA, Deeter RG et al. Therapy of otitis media. Clin Pharm. 1990; 9:15-34.
5. Bluestone CD. Otitis media in children: to treat or not to treat? N Engl J Med. 1902; 306:1399-404.
6. Weiss JC, Melman ST. Cost effectiveness in the choice of antibiotics for the initial treatment of otitis media in children: a decision analysis approach. Pediatr Infect Dis. 1988; 7:23-6.